Aeglea Biotherapeutics shares owned by Schroder Investment Management Group
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Schroder Investment Management Group
from 13F filings
Historical chart of Schroder Investment Management Group investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Schroder Investment Management Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by Schroder Investment Management Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.8M | 108k | 16.36 |
| 2025-06-30 | $2.0M | 130k | 15.22 |
| 2025-03-31 | $1.9M | 109k | 17.94 |
| 2024-12-31 | $2.6M | 114k | 22.54 |
More positions owned by Schroder Investment Management Group
View all positions for Schroder Investment Management Group